
Non-hormonal intrauterine devices (IUDs) are a form of long-term, reversible contraception that do not release hormones into the body. They primarily use copper to prevent pregnancy.
The global Non-Hormonal IUDs market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The 鈥淣on-Hormonal IUDs Industry Forecast鈥 looks at past sales and reviews total world Non-Hormonal IUDs sales in 2023, providing a comprehensive analysis by region and market sector of projected Non-Hormonal IUDs sales for 2024 through 2030. With Non-Hormonal IUDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-Hormonal IUDs industry.
This Insight Report provides a comprehensive analysis of the global Non-Hormonal IUDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-Hormonal IUDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥 unique position in an accelerating global Non-Hormonal IUDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-Hormonal IUDs and breaks down the forecast by Type, by Age, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-Hormonal IUDs.
United States market for Non-Hormonal IUDs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Non-Hormonal IUDs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Non-Hormonal IUDs is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Non-Hormonal IUDs players cover CooperSurgical, Williams Medical Supplies, Laboratoire 7 MED, Bayer, Durbin, etc. In terms of revenue, the global two largest companies occupied for a share nearly
% in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-Hormonal IUDs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
T-shaped
U-shaped
Segmentation by Age:
Below 35 Years Old
35 Years Old and Above
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
CooperSurgical
Williams Medical Supplies
Laboratoire 7 MED
Bayer
Durbin
Laboratoire CCD
Prosan
OCON
SMB Corporation of India
Key Questions Addressed in this Report
What is the 10-year outlook for the global Non-Hormonal IUDs market?
What factors are driving Non-Hormonal IUDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Non-Hormonal IUDs market opportunities vary by end market size?
How does Non-Hormonal IUDs break out by Type, by Age?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Non-Hormonal IUDs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Non-Hormonal IUDs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Non-Hormonal IUDs by Country/Region, 2019, 2023 & 2030
2.2 Non-Hormonal IUDs Segment by Type
2.2.1 T-shaped
2.2.2 U-shaped
2.3 Non-Hormonal IUDs Sales by Type
2.3.1 Global Non-Hormonal IUDs Sales 麻豆原创 Share by Type (2019-2024)
2.3.2 Global Non-Hormonal IUDs Revenue and 麻豆原创 Share by Type (2019-2024)
2.3.3 Global Non-Hormonal IUDs Sale Price by Type (2019-2024)
2.4 Non-Hormonal IUDs Segment by Age
2.4.1 Below 35 Years Old
2.4.2 35 Years Old and Above
2.5 Non-Hormonal IUDs Sales by Age
2.5.1 Global Non-Hormonal IUDs Sale 麻豆原创 Share by Age (2019-2024)
2.5.2 Global Non-Hormonal IUDs Revenue and 麻豆原创 Share by Age (2019-2024)
2.5.3 Global Non-Hormonal IUDs Sale Price by Age (2019-2024)
3 Global by Company
3.1 Global Non-Hormonal IUDs Breakdown Data by Company
3.1.1 Global Non-Hormonal IUDs Annual Sales by Company (2019-2024)
3.1.2 Global Non-Hormonal IUDs Sales 麻豆原创 Share by Company (2019-2024)
3.2 Global Non-Hormonal IUDs Annual Revenue by Company (2019-2024)
3.2.1 Global Non-Hormonal IUDs Revenue by Company (2019-2024)
3.2.2 Global Non-Hormonal IUDs Revenue 麻豆原创 Share by Company (2019-2024)
3.3 Global Non-Hormonal IUDs Sale Price by Company
3.4 Key Manufacturers Non-Hormonal IUDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-Hormonal IUDs Product Location Distribution
3.4.2 Players Non-Hormonal IUDs Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Non-Hormonal IUDs by Geographic Region
4.1 World Historic Non-Hormonal IUDs 麻豆原创 Size by Geographic Region (2019-2024)
4.1.1 Global Non-Hormonal IUDs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Non-Hormonal IUDs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Non-Hormonal IUDs 麻豆原创 Size by Country/Region (2019-2024)
4.2.1 Global Non-Hormonal IUDs Annual Sales by Country/Region (2019-2024)
4.2.2 Global Non-Hormonal IUDs Annual Revenue by Country/Region (2019-2024)
4.3 Americas Non-Hormonal IUDs Sales Growth
4.4 APAC Non-Hormonal IUDs Sales Growth
4.5 Europe Non-Hormonal IUDs Sales Growth
4.6 Middle East & Africa Non-Hormonal IUDs Sales Growth
5 Americas
5.1 Americas Non-Hormonal IUDs Sales by Country
5.1.1 Americas Non-Hormonal IUDs Sales by Country (2019-2024)
5.1.2 Americas Non-Hormonal IUDs Revenue by Country (2019-2024)
5.2 Americas Non-Hormonal IUDs Sales by Type (2019-2024)
5.3 Americas Non-Hormonal IUDs Sales by Age (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-Hormonal IUDs Sales by Region
6.1.1 APAC Non-Hormonal IUDs Sales by Region (2019-2024)
6.1.2 APAC Non-Hormonal IUDs Revenue by Region (2019-2024)
6.2 APAC Non-Hormonal IUDs Sales by Type (2019-2024)
6.3 APAC Non-Hormonal IUDs Sales by Age (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-Hormonal IUDs by Country
7.1.1 Europe Non-Hormonal IUDs Sales by Country (2019-2024)
7.1.2 Europe Non-Hormonal IUDs Revenue by Country (2019-2024)
7.2 Europe Non-Hormonal IUDs Sales by Type (2019-2024)
7.3 Europe Non-Hormonal IUDs Sales by Age (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-Hormonal IUDs by Country
8.1.1 Middle East & Africa Non-Hormonal IUDs Sales by Country (2019-2024)
8.1.2 Middle East & Africa Non-Hormonal IUDs Revenue by Country (2019-2024)
8.2 Middle East & Africa Non-Hormonal IUDs Sales by Type (2019-2024)
8.3 Middle East & Africa Non-Hormonal IUDs Sales by Age (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-Hormonal IUDs
10.3 Manufacturing Process Analysis of Non-Hormonal IUDs
10.4 Industry Chain Structure of Non-Hormonal IUDs
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-Hormonal IUDs Distributors
11.3 Non-Hormonal IUDs Customer
12 World Forecast Review for Non-Hormonal IUDs by Geographic Region
12.1 Global Non-Hormonal IUDs 麻豆原创 Size Forecast by Region
12.1.1 Global Non-Hormonal IUDs Forecast by Region (2025-2030)
12.1.2 Global Non-Hormonal IUDs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global Non-Hormonal IUDs Forecast by Type (2025-2030)
12.7 Global Non-Hormonal IUDs Forecast by Age (2025-2030)
13 Key Players Analysis
13.1 CooperSurgical
13.1.1 CooperSurgical Company Information
13.1.2 CooperSurgical Non-Hormonal IUDs Product Portfolios and Specifications
13.1.3 CooperSurgical Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 CooperSurgical Main Business Overview
13.1.5 CooperSurgical Latest Developments
13.2 Williams Medical Supplies
13.2.1 Williams Medical Supplies Company Information
13.2.2 Williams Medical Supplies Non-Hormonal IUDs Product Portfolios and Specifications
13.2.3 Williams Medical Supplies Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Williams Medical Supplies Main Business Overview
13.2.5 Williams Medical Supplies Latest Developments
13.3 Laboratoire 7 MED
13.3.1 Laboratoire 7 MED Company Information
13.3.2 Laboratoire 7 MED Non-Hormonal IUDs Product Portfolios and Specifications
13.3.3 Laboratoire 7 MED Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Laboratoire 7 MED Main Business Overview
13.3.5 Laboratoire 7 MED Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Non-Hormonal IUDs Product Portfolios and Specifications
13.4.3 Bayer Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Durbin
13.5.1 Durbin Company Information
13.5.2 Durbin Non-Hormonal IUDs Product Portfolios and Specifications
13.5.3 Durbin Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Durbin Main Business Overview
13.5.5 Durbin Latest Developments
13.6 Laboratoire CCD
13.6.1 Laboratoire CCD Company Information
13.6.2 Laboratoire CCD Non-Hormonal IUDs Product Portfolios and Specifications
13.6.3 Laboratoire CCD Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Laboratoire CCD Main Business Overview
13.6.5 Laboratoire CCD Latest Developments
13.7 Prosan
13.7.1 Prosan Company Information
13.7.2 Prosan Non-Hormonal IUDs Product Portfolios and Specifications
13.7.3 Prosan Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Prosan Main Business Overview
13.7.5 Prosan Latest Developments
13.8 OCON
13.8.1 OCON Company Information
13.8.2 OCON Non-Hormonal IUDs Product Portfolios and Specifications
13.8.3 OCON Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 OCON Main Business Overview
13.8.5 OCON Latest Developments
13.9 SMB Corporation of India
13.9.1 SMB Corporation of India Company Information
13.9.2 SMB Corporation of India Non-Hormonal IUDs Product Portfolios and Specifications
13.9.3 SMB Corporation of India Non-Hormonal IUDs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 SMB Corporation of India Main Business Overview
13.9.5 SMB Corporation of India Latest Developments
14 Research Findings and Conclusion
听
听
*If Applicable.
